(Q34463416)

2 August 2017

1 reference

title

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Lieberman JA

1

1 reference

2 August 2017

Perkins D

2

1 reference

2 August 2017

Belger A

3

1 reference

2 August 2017

Chakos M

4

1 reference

2 August 2017

Jarskog F

5

1 reference

2 August 2017

Boteva K

6

1 reference

2 August 2017

Gilmore J

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

published in

Biological Psychiatry

1 reference

2 August 2017

volume

50

1 reference

2 August 2017

issue

11

1 reference

2 August 2017

page(s)

884-897

1 reference

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Duration of untreated psychosis predicts treatment outcome in an early psychosis program.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

[Schizophrenia--neurosis]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Advancing a neurodevelopmental origin for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Defining treatment refractoriness in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Association of prenatal and perinatal complications with subsequent bipolar disorder and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

7. Psychopathology and the question of neurodevelopmental or neurodegenerative disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Impaired attention, genetics, and the pathophysiology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Oxidative stress, glutamate, and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Ventricular enlargement in poor-outcome schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Causes and consequences of duration of untreated psychosis in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

High-risk research in schizophrenia: a summary of what has been learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Neurobiologic antecedents of schizophrenia in children. Evidence for an inherited, congenital neurointegrative defect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Causes and consequences of the gender difference in age at onset of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

The early origins of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Increased dopamine transmission in schizophrenia: relationship to illness phases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Catching up on schizophrenia: natural history and neurobiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Psychobiologic correlates of treatment response in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Qualitative assessment of brain morphology in acute and chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Longitudinal study of brain morphology in first episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Delayed detection of psychosis: causes, consequences, and effect on public health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Time course and biologic correlates of treatment response in first-episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Early detection and intervention in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Duration of psychosis and outcome in first-episode schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

A selective review of recent North American long-term followup studies of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Early detection and intervention in schizophrenia: research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

People at risk of schizophrenia and other psychoses: comments on the Edinburgh High-Risk Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

EPPIC: an evolving system of early detection and optimal management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Is schizophrenia a neurodevelopmental disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Progression of cerebroventricular enlargement and the subtyping of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Information processing and attentional functioning in the developmental course of schizophrenic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Asymmetries in Hemispheric Control of Attention in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Preventing severe mental illnesses--new prospects and ethical challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

The use of a priori knowledge to quantify short echo in vivo1h mr spectra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Course of treatment response in first-episode and chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Codistribution of a sensory gating deficit and schizophrenia in multi-affected families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Prediction of adult-onset schizophrenia from childhood home movies of the patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Immunoelectron microscopic study of glutamate inputs from the retrosplenial granular cortex to identified thalamocortical projection neurons in the anterior thalamus of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Implications of normal brain development for the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Retinoid signaling distinguishes a subpopulation of olfactory receptor neurons in the developing and adult mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Case-finding instruments for depression. Two questions are as good as many

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

13. Early intervention with neuroleptics may decrease the l long-term morbidity of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Early intervention for schizophrenia: can the course of the illness be altered?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901303-8

10.1016/S0006-3223(01)01303-8

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference